Cork, Ireland (ots/PRNewswire) - Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative study was conducted across 26 ...
Belfast, Northern Ireland (ots/PRNewswire) - Gunvor Group, one of the world's largest physical energy commodities traders, has made an investment in Artemis Technologies as a part of the company's commitment to developing nonhydrocarbon solutions to maritime transportation. The investment by Gunvor follows the recent award of a £33 million UK Government innovation ...
Ashburn, Va and Dublin, Ireland (ots/PRNewswire) - Chirisa Holdings Inc. today announces that 365 Data Centers, a leading hybrid data center and network solutions provider, has been acquired by Stonecourt Capital LP. Chirisa has led the investment in 365 since 2017 alongside CEO Bob DeSantis and co-investors Lumerity Capital, Turning Rock Partners and Longboat Advisors. Over that time, 365 has developed into one of the largest privately-owned operators across the eastern ...
Cork, Ireland (ots/PRNewswire) - Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea. At a recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), Hovione ...
Dublin, Ireland (ots/PRNewswire) - Yesterday the European Commission (EC) announced that it had fined Scania EUR880 million for its participation in the 1997-2011 truck cartel. This is the second highest fine ever imposed on an individual company by the EC. Last Friday 22 September 2017, the District Court of ...
Cork, Ireland (ots/PRNewswire) - - Viral Hepatitis Research and Development to Focus on Addressing Significant Unmet Needs in Chronic Hepatitis B Janssen Sciences Ireland UC (Janssen), today announced a strategic decision to discontinue further development of the investigational hepatitis C treatment regimen JNJ-4178, a combination of three direct acting antivirals - AL-335, odalasvir and simeprevir. The ongoing phase II ...
Caisse de dépôt et placement du Québec
Montréal and Shannon, Ireland (ots/PRNewswire) - - CDPQ to provide strategic capital over four years to create an aircraft leasing and financing platform alongside world-class operator GECAS - Platform will provide GECAS with increased flexibility to support future growth - Investment marks new milestone in the ...
Coleraine, Ireland (ots/PRNewswire) - Over 250 iconic landmarks and sites around the world will be illuminated green over the coming days - as part of Tourism Ireland's 2017 Global Greening initiative to celebrate the island of Ireland and St Patrick. The annual initiative, now in its eighth year, which sees a host of major landmarks around the world turn green for St ...
Cork, Ireland (ots/PRNewswire) - Includes several late breaking and oral presentations from across R&D pipeline Highlights potential of R&D pipeline to deliver several new hepatitis B and C regimens Janssen Sciences Ireland UC and certain Janssen affiliates* today announced it will present thirteen abstracts ...
Cork, Ireland (ots/PRNewswire) - Intramuscular 2-drug maintenance therapy demonstrates comparable antiviral activity to daily oral 3-drug combination Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, (Janssen) announced 32-week data from an ongoing phase IIb study. A ...
Cork, Ireland (ots/PRNewswire) - Results from ongoing phase IIb Week 32 study show that if successfully developed and approved, people living with HIV could potentially maintain viral suppression Janssen Sciences Ireland UC (Janssen), today formalized its collaboration with ViiV Healthcare on phase III development ...
Cork, Ireland (ots/PRNewswire) - Injectable combinations once every 4 or 8 weeks show comparable efficacy versus daily oral combination therapy Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced that Phase IIb data studying a combination regimen of ...
Limerick, Ireland (ots/PRNewswire) - The University of Limerick has received one of Europe's most powerful microscopes supported by NT-MDT, a world-leading manufacturer of atomic force based microscopes (AFM). NT-MDT recently installed a unique Atomic Force Microscope with RAMAN, TERS, and SNOM capabilities (NTEGRA Spectra). This is a very rare device that combines AFM ...
Dublin, Ireland (ots/PRNewswire) - - Expected to Create a Leader in Global Specialty Insurance and Reinsurance Markets - Expected to Create Double Digit EPS and Meaningful ROE Accretion XL Group plc today announced that it has entered into an agreement under which XL will offer to acquire all of the capital stock of Catlin Group Limited to form a combined business which is expected to have a leading presence in the global ...
Cork, Ireland (ots/PRNewswire) - -- Two Companies to also Collaborate on the Further Development of Complera(R), Marketed as Eviplera(R) in the European Union -- Janssen R&D Ireland (Janssen) announced today an amendment to its existing agreement with Gilead Sciences, Inc. (Gilead), initially established in 2011, ...
Shire Pharmaceuticals Group Plc
Dublin, Ireland (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Shire plc ("Shire" or the "Company") notes today's announcement by AbbVie Inc. ("AbbVie") repeating its proposal of May 30, 2014, which comprised GBP20.44 in cash and 0.7988 AbbVie shares per Shire ...
Cork, Ireland (ots/PRNewswire) - Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT(R)) and ViiV's ...
Cork, Ireland (ots/PRNewswire) - Janssen R&D Ireland (Janssen) announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 (HIV-1) medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis (PrEP) ...
Bushmills, Ireland (ots/PRNewswire) - Bushmills Live: International indie artists take to the stage at age-old distillery Global stars including Of Monsters and Men and Jake Bugg, together with friends Foy Vance, Willy Mason and Iain Archer, gave electrifying performances last night at Bushmills Live - the festival ...